Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Maria Silvina Frech, Ph.D., M.S.

Program Officer | Breast and Gynecologic Cancer

Email: maria.frech@nih.gov
Phone: 240-276-5302
Room: 5E320

Biography

Maria Silvina Frech, Ph.D., M.S., serves as Program Officer in the Breast and Gynecologic Cancer Research Group (BGCR), Division of Cancer Prevention (DCP), National Cancer Institute (NCI).

In this role, she oversees a portfolio of cooperative agreements that support two international clinical research networks with the goal of improving cervical cancer screening, management, and precancer treatment for women with HIV: The US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet) and the HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network. She collaborates with colleagues from other NCI Divisions and Centers focused on advancing implementation research initiatives.  

Dr. Frech received a B.S. in Pharmaceutical Sciences from the Universidad Nacional de Rosario, Argentina; a M.S. in Biochemistry and Molecular Biology; and a Ph.D. in Tumor Biology, from Georgetown University, studying the role of Estrogen Receptor and Cyclin D1 in mammary gland development and carcinogenesis. Dr. Frech’s work has focused on advancing global cancer research and control in Latin America. More recently, she held strategic leadership roles in a non-profit organization that developed an implementation framework for health systems strengthening and cancer care improvement. Dr. Frech received an NCI Director Award for supporting the Cancer Control Leadership Forum program in 2016 and has authored publications in high-impact journals such as The Lancet, the Journal of Global Oncology, Cancer Research, and Science Translational Medicine.